Photo of Debbie Lesko
R United States House · District 8 · Arizona

Rep. Debbie Lesko

Compare
Total votes
2,168
all sessions
Attendance
92%
180 missed
Lower than 90% of chamber peers
With party
91%
of cast votes
Near the chamber average
Bipartisan score
5%
crosses aisle rarely
Near the chamber average
Sponsored
934
bills & resolutions
Near the chamber average
Committees
0
assignments
934 bills and resolutions

Sponsored bills

Total
934
Primary
69
Co-sponsor
865
This page
934
matching current filters
Co-sponsor HRES 352
In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 19
In committee · United States House · Co-sponsor
Lower Costs, More Cures Act of 2021

Lower Costs, More Cures Act of 2021 This bill establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; caps annual out-of-pocket spending under the Medicare prescription drug benefit; allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and allows states to include in the Medicaid Drug Rebate Program covered outpatient drugs that are provided as part of physician or outpatient hospital services. The bill also generally modifies other provisions relating to the regulation and costs of generic and brand-name drugs. Among other changes, the bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product; permanently allows high deductible health plans to waive deductibles for insulin and associated products; and establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2718
In committee · United States House · Co-sponsor
Maximum Pressure Act

Maximum Pressure Act This bill expands sanctions and economic penalties on Iran. It also restricts the President from unilaterally lifting or waiving the sanctions or penalties and increases congressional oversight of them. Specifically, the bill requires the President to impose visa- and asset-blocking sanctions. Additionally, it modifies existing sanctions, including by (1) providing statutory authority for executive orders imposing sanctions; (2) applying sanctions to additional sectors of Iran's economy; and (3) broadening sanctionable conduct to cover, for example, assisting Iran with the acquisition of ballistic missiles and the complicity of Iranian officials in human rights violations in specified countries. The bill also requires reporting on licenses that authorize activities subject to sanctions. The bill prohibits U.S. representatives at the International Monetary Fund from voting to allow Iran's access to special drawing rights (a currency support tool) and places restrictions on financial transactions with Iran. The restrictions include requiring domestic financial institutions to implement special measures with respect to foreign financial institutions that conduct significant transactions connected to the Instrument in Support of Trade Exchanges (a European mechanism that bypasses U.S. sanctions when carrying out trade with Iran). The Department of State must maintain the Islamic Revolutionary Guard Corps' designation as a terrorist organization and must designate Ansharallah (or Houthis), which operates in Syria, as a foreign terrorist organization. The bill also requires reports on U.S. sanctions concerning Iran, the status of Iran's nuclear weapons program, and other matters.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2708
In committee · United States House · Co-sponsor
Sunshine for Regulatory Decrees and Settlements Act of 2021

Sunshine for Regulatory Decrees and Settlements Act of 2021 This bill establishes transparency and public accountability standards for federal agencies with respect to (1) certain civil actions seeking to compel agency action, and (2) related consent decrees and settlement agreements. For example, an agency must publish a complaint filed against it within 15 days. Additionally, settlement proceedings must be conducted through mediation or an alternative dispute resolution program of the court, and those proceedings must include intervening parties. The bill also creates a presumption in favor of a motion to intervene in settlement proceedings. Further, at least 60 days prior to entering a consent decree or settlement agreement, an agency must publish, and accept and respond to public comment on, the proposed agreement or decree. An agency also must provide the court with the administrative record, a summary of the public comments, and access to the record of any public hearings on the proposed decree or agreement. The Department of Justice, or the agency litigating a matter independently, must certify to the court its approval of certain terms included in an agreement or decree, including terms that convert a discretionary authority into a nondiscretionary duty. A court may not approve a consent decree or settlement agreement unless the agency has sufficient time and procedures to comply with federal administrative procedures, other rulemaking statutes, and applicable executive orders. Finally, courts must review a consent decree or settlement if an agency files a motion to modify the decree or agreement on the basis of changed facts or circumstances.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2430
In committee · United States House · Co-sponsor
Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act

Temporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act This bill extends until May 6, 2022, the temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances in schedule I of the Controlled Substances Act. The temporary order expires on May 6, 2021.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2317
In committee · United States House · Co-sponsor
We Will Not Comply Act

We Will Not Comply Act This bill prohibits discrimination based on an individual's COVID-19 vaccination status. Specifically, the bill bars certain commercial businesses from discriminating on the basis of an individual's COVID-19 vaccination status. In addition, the bill generally prohibits using federal funds to establish or enforce COVID-19 vaccination requirements. Further, federal funds may not be used to compel an individual with a religious objection to vaccinations to receive a vaccine. The bill also prohibits federal funding of educational institutions that require an individual to receive a COVID-19 vaccine to participate in academic or extracurricular activities. Additionally, a public school or public college may not deny access to the school or college based on whether an individual has received a vaccine, including the COVID-19 vaccine. Furthermore, air carriers may not deny an individual access to air transportation solely on the basis of COVID-19 vaccination status. The bill also prohibits proof of a COVID-19 vaccine as a condition of receiving a U.S. passport. The bill establishes a private right of action for individuals who have been discriminated against based on COVID-19 vaccine status or failure to comply with a requirement to wear a face covering.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2192
In committee · United States House · Co-sponsor
Camp Lejeune Justice Act of 2021

Camp Lejeune Justice Act of 2021 This bill allows certain individuals to sue and recover damages for harm from exposure to contaminated water at Camp Lejeune in North Carolina between August 1, 1953, and December 31, 1987. This action is available only to individuals who were exposed to contaminated water for at least 30 days. The bill prohibits the U.S. government from asserting specified immunity from litigation in response to such a lawsuit. The bill also prohibits an individual who brings such an action from bringing a separate tort action against the United States based on the same harm.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2076
In committee · United States House · Co-sponsor
COVID–19 Border Protection (CBP) Act

COVID-19 Border Protection (CBP) Act This bill requires the Department of Homeland Security (DHS) to devise and implement a strategy to ensure that no alien with COVID-19 (i.e., coronavirus disease 2019) in DHS or Department of Health and Human Services custody may be released into the community during a public health emergency related to COVID-19. Funds previously provided to the Department of State for supporting international efforts to help migrants and refugees respond to COVID-19 shall be transferred to DHS to implement this strategy.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 5586
In committee · United States House · Co-sponsor
Prohibiting IRS Financial Surveillance Act

Prohibiting IRS Financial Surveillance Act This bill prohibits the Department of the Treasury from requiring a financial institution to report the transfers into and out of a financial account. This prohibition does not apply to laws or regulations in effect on October 1, 2021.

In committee Oct 15, 2021 1 co-sponsor
Co-sponsor HR 250
In committee · United States House · Co-sponsor
January 8<sup>th</sup>National Memorial Act

January 8th National Memorial Act This bill directs the Department of the Interior to establish the January 8th National Memorial in Tucson, Arizona, as an affiliated area of the National Park System in commemoration of the shooting of Congresswoman Gabrielle Giffords and 18 others in Tucson on January 8, 2011. The January 8th Memorial Foundation shall transfer to Pima County, Arizona, amounts equal to final funding pledges, in addition to the amounts that the foundation has raised and transferred to the county for the construction of the memorial. The memorial shall be constructed on property owned by Pima County. The bill makes the county responsible for the management of the construction contract for the memorial through the use of funds provided by the foundation. The foundation shall cease operations after (1) final funding pledge amounts have been paid to Pima County, and (2) construction of the memorial has been completed. Pima County shall (1) be the memorial's management entity, and (2) be responsible for the construction and operation of the memorial. Interior shall develop a general management plan for the memorial.

In committee Oct 14, 2021 1 co-sponsor
Showing 651 to 660 of 934 bills
Previous 1 … 65 66 67 … 94 Next